Wall Street brokerages forecast that Infinity Pharmaceuticals, Inc. (NASDAQ:INFI – Get Rating) will report $520,000.00 in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for Infinity Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $200,000.00 and the highest estimate coming in at $680,000.00. Infinity Pharmaceuticals […]
Wall Street brokerages expect Infinity Pharmaceuticals, Inc. (NASDAQ:INFI – Get Rating) to post $400,000.00 in sales for the current fiscal quarter, according to Zacks. Four analysts have made estimates for Infinity Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $200,000.00 and the highest estimate coming in at $480,000.00. Infinity Pharmaceuticals reported sales of […]
AstraZeneca (NASDAQ:AZN – Get Rating) and Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership. Profitability This table compares AstraZeneca and Infinity Pharmaceuticals’ net margins, return […]
Wall Street analysts expect Infinity Pharmaceuticals, Inc. (NASDAQ:INFI – Get Rating) to report $410,000.00 in sales for the current quarter, according to Zacks. Five analysts have issued estimates for Infinity Pharmaceuticals’ earnings. The highest sales estimate is $550,000.00 and the lowest is $200,000.00. Infinity Pharmaceuticals reported sales of $440,000.00 in the same quarter last year, […]